Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

碘化油 医学 肝细胞癌 经导管动脉化疗栓塞 随机对照试验 栓塞 临床终点 单变量分析 外科 内科学 胃肠病学 多元分析
作者
Chung‐Mau Lo,Hys Ngan,Wai‐Kuen Tso,Chi‐Leung Liu,Chi‐Ming Lam,Ronnie Tung‐Ping Poon,Irene Oi‐Lin Ng,John Wong
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:35 (5): 1164-1171 被引量:2602
标识
DOI:10.1053/jhep.2002.33156
摘要

This randomized, controlled trial assessed the efficacy of transarterial Lipiodol (Lipiodol Ultrafluide, Laboratoire Guerbet, Aulnay-Sous-Bois, France) chemoembolization in patients with unresectable hepatocellular carcinoma. From March 1996 to October 1997, 80 out of 279 Asian patients with newly diagnosed unresectable hepatocellular carcinoma fulfilled the entry criteria and randomly were assigned to treatment with chemoembolization using a variable dose of an emulsion of cisplatin in Lipiodol and gelatin-sponge particles injected through the hepatic artery (chemoembolization group, 40 patients) or symptomatic treatment (control group, 40 patients). One patient assigned to the control group secondarily was excluded because of unrecognized systemic metastasis. Chemoembolization was repeated every 2 to 3 months unless there was evidence of contraindications or progressive disease. Survival was the main end point. The chemoembolization group received a total of 192 courses of chemoembolization with a median of 4.5 (range, 1-15) courses per patient. Chemoembolization resulted in a marked tumor response, and the actuarial survival was significantly better in the chemoembolization group (1 year, 57%; 2 years, 31%; 3 years, 26%) than in the control group (1 year, 32%; 2 years, 11%; 3 years, 3%; P = .002). When adjustments for baseline variables that were prognostic on univariate analysis were made with a multivariate Cox model, the survival benefit of chemoembolization remained significant (relative risk of death, 0.49; 95% CI, 0.29-0.81; P = .006). Although death from liver failure was more frequent in patients who received chemoembolization, the liver functions of the survivors were not significantly different. In conclusion, in Asian patients with unresectable hepatocellular carcinoma, transarterial Lipiodol chemoembolization significantly improves survival and is an effective form of treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
罗奕芳发布了新的文献求助10
刚刚
xiaorere完成签到,获得积分10
刚刚
刚刚
刚刚
刚刚
MADKAI发布了新的文献求助10
1秒前
MADKAI发布了新的文献求助10
1秒前
1秒前
2秒前
2秒前
2秒前
MADKAI发布了新的文献求助10
2秒前
职克琪发布了新的文献求助10
2秒前
2秒前
呼呼呼完成签到,获得积分10
3秒前
蛋挞完成签到 ,获得积分10
3秒前
4秒前
MADKAI发布了新的文献求助10
4秒前
MADKAI发布了新的文献求助10
4秒前
科研通AI6.2的应助被QianQianONE采纳,获得10
5秒前
姚昂发布了新的文献求助10
5秒前
5秒前
Yxblin发布了新的文献求助10
5秒前
lucky完成签到 ,获得积分10
5秒前
小沅发布了新的文献求助10
6秒前
6秒前
Jyz发布了新的文献求助10
6秒前
左左子完成签到,获得积分10
6秒前
直率的芷云完成签到,获得积分10
6秒前
呼呼呼发布了新的文献求助10
6秒前
6秒前
7秒前
7秒前
花花完成签到,获得积分20
7秒前
MADKAI发布了新的文献求助10
8秒前
MADKAI发布了新的文献求助10
8秒前
ding的应助被ygl采纳,获得10
8秒前
MADKAI发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8164555
求助须知:如何正确求助?哪些是违规求助? 9558341
关于积分的说明 21745170
捐赠科研通 7755092
什么是DOI,文献DOI怎么找? 3428591
关于科研通互助平台的介绍 2553128
邀请新用户注册赠送积分活动 2473151